Next generation sequencing (NGS)

The Biotech Institute possesses illumina MiniSeq NGS technology for accurate and reliable sequencing in various applications extending from microbial Whole Genome Sequencing (WGS) to Whole Clinical Exome Sequencing (WCES).

Selected Applications

  • Microbial Whole Genome Sequencing
  • Cancer genomics e.g. BRCA1/BRCA2, solid tumor panel, myeloid tumours, lung cancer, immune response panel, etc
  • Human Clinical Exome Sequencing
  • TB Genotyping for drug resistance testing
  • HPV/STI genotyping
  • HIV genotyping for drug resistance testing
  • Non-invasive prenatal paternity testing (NIPPT)
  • Custom NGS sequencing


Server IP: